About Keratin, type II cuticular Hb1
Keratin, type II cuticular Hb1 (KRT81) is a protein
from Homo sapiens identified by UniProt accession
Q14533, 505 residues long.
MolForge cross-references it against 0 known binders and
69 disease associations.
Target properties
| Protein name | Keratin, type II cuticular Hb1 |
| UniProt accession | Q14533 |
| Gene | KRT81 |
| Organism | Homo sapiens |
| Length | 505 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (69)
Diseases linked to this target (Open Targets).
- monilethrix · score 0.70
- head and neck squamous cell carcinoma · score 0.19
- prostate adenocarcinoma · score 0.19
- glioblastoma multiforme · score 0.18
- breast adenocarcinoma · score 0.18
- brain volume measurement · score 0.13
- neoplasm · score 0.09
- triple-negative breast cancer · score 0.08
- lung adenocarcinoma · score 0.07
- plasma fibronectin deficiency · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14533-F1 | alphafold | PREDICTED | 71.94 | — |
Amino-acid sequence (505 residues)
MTCGSGFGGR AFSCISACGP RPGRCCITAA PYRGISCYRG LTGGFGSHSV CGGFRAGSCG RSFGYRSGGV CGPSPPCITT VSVNESLLTP LNLEIDPNAQ CVKQEEKEQI KSLNSRFAAF IDKVRFLEQQ NKLLETKLQF YQNRECCQSN LEPLFEGYIE TLRREAECVE ADSGRLASEL NHVQEVLEGY KKKYEEEVSL RATAENEFVA LKKDVDCAYL RKSDLEANVE ALIQEIDFLR RLYEEEILIL QSHISDTSVV VKLDNSRDLN MDCIIAEIKA QYDDIVTRSR AEAESWYRSK CEEMKATVIR HGETLRRTKE EINELNRMIQ RLTAEVENAK CQNSKLEAAV AQSEQQGEAA LSDARCKLAE LEGALQKAKQ DMACLIREYQ EVMNSKLGLD IEIATYRRLL EGEEQRLCEG IGAVNVCVSS SRGGVVCGDL CVSGSRPVTG SVCSAPCNGN VAVSTGLCAP CGQLNTTCGG GSCGVGSCGI SSLGVGSCGS SCRKC
Explore Keratin, type II cuticular Hb1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets